Comparer des méthodes

	Échelle d'évaluation de la ménopause (MRS)	Échelle de détresse sexuelle féminine (FSDS)
Domaine	Urologie et gynécologie	Urologie et gynécologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2000	2002
Auteur d'origine	Heinemann et al.	Derogatis et al.
Type	Self-report symptom scale	Self-report distress scale
Source fondatrice	Heinemann, K., Assmann, A., Möhner, S., & Schneider, H. P. (2004). The Menopause Rating Scale (MRS) as outcome measure for hormone replacement therapy. Menopause, 11(5), 571–578.	Derogatis, L. R., Clayton, A. H., Lewis-D'Agostino, D. J., Wunderlich, G., & Fu, Y. (2008). Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder and female sexual arousal disorder. Journal of Sexual & Marital Therapy, 34(2), 94–118.
Alias	MRS	FSDS, FSDS-R
Apparentées	3	3
Résumé	The MRS is an 11-item self-report symptom scale designed to assess the frequency and severity of menopausal symptoms including vasomotor complaints, psychologic symptoms, and urogenital manifestations. Developed by Heinemann and colleagues in Germany and first published in 2000, it has become the most widely used symptom measure in menopause research and clinical practice across 60+ countries and languages.	The FSDS is a brief self-report measure designed to assess psychological distress specifically related to female sexual dysfunction. Originally developed by Derogatis and colleagues and published in 2002, the revised version (FSDS-R) comprises 13 items measuring distress about sexual concerns, with particular utility in identifying women who seek treatment for sexual problems versus those with asymptomatic sexual dysfunction. It is widely used in clinical practice and research to distinguish distress-inducing sexual dysfunction from normative sexual variation.